Skip to Content
Biotechnology and health

Pandemics through the decades

A viral disease has a way of reminding us that technology can’t help us if it’s not paired with human cooperation.
April 15, 2020
June 1956

June 1956

From “The First Great Epidemic of History”: Since the beginning of recorded history the people of this world have been molested by a long series of awesome epidemics, several of which have brought mankind dangerously close to extinction. The worst of them all is generally thought to have been the so-called Black Death, which ravaged the known world during most of the second half of the Fourteenth Century. Even more extensive in scope than the Black Death was an epidemic, or pandemic, which occurred nearly 600 years later. This was the influenza outbreak of the Twentieth Century, which began in Europe in May or June of 1918 and in three waves traveled literally throughout the world. It is probable, in fact, that the total carnage from this recent epidemic exceeded that of the Black Death.

October 1995 cover

October 1995

From “Thinking Like a Virus”: Why did it take less than two weeks to find the mutant coronavirus responsible for Severe Acute Respiratory Syndrome, or SARS, while it took the better part of three years to find HIV? There are many reasons—including better technology and a less elusive viral target—but don’t discount the unprecedented level of worldwide communication among SARS researchers.

The success of a global research network in identifying the pathogen is an example of the huge payoff that can result when researchers put aside visions of patents and glory for their individual laboratories and let their work behave more like, well, a virus. After all, the hallmark of an opportunistic virus like the one that causes SARS is its ability to spread quickly. Those mounting a response need to disseminate their information and innovation just as rapidly.

July 2003 cover

July/August 2003

From “Controlling Infectious Diseases”: These are global problems transcending political and national boundaries. An infection may come to light anywhere in the world and span continents within days or weeks. Recognizing as much, several expert groups have concluded that a surveillance system to spot emerging infections—an “early warning system”—is an essential first line of defense. But so far we aren’t even close to having such a system … As of now, humanity remains vulnerable to a staggering array of infections. We have no unified system for global surveillance, let alone one for response. Some of us have been paralyzed by complacency—thinking, wrongly, that the threat of infectious diseases is past. Others have been equally paralyzed by defeatism, perhaps feeling that it is too difficult to build the systems needed to protect us. But even imperfect systems are better than none at all.

Deep Dive

Biotechnology and health

FDA advisors just said no to the use of MDMA as a therapy

The studies demonstrating MDMA’s efficacy against PTSD left experts with too many questions to greenlight the treatment.

Biotech companies are trying to make milk without cows

The bird flu crisis on dairy farms could boost interest in milk protein manufactured in microorganisms and plants. 

Is this the end of animal testing?

Researchers are increasingly turning to organ-on-a-chip technology for drug testing and other applications.

What’s next for MDMA

The FDA is poised to approve the notorious party drug as a therapy. Here’s what it means, and where similar drugs stand in the US. 

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.